9 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $311M | -$178M | 0.0% | -51.7% | -$237000 | $153M | $51M |
| 2024 | $307M | -$70M | 0.0% | -22.8% | $13M | $382M | $250M |
| 2023 | $296M | -$118M | 0.0% | -42.9% | -$34M | $228M | $106M |
| 2022 | $276M | -$137M | 0.0% | -50.7% | -$37M | $227M | $116M |
| 2021 | $242M | -$153M | 0.0% | -59.4% | -$34M | $181M | $193M |
| 2020 | $189M | -$115M | 0.0% | -50.9% | -$34M | $169M | $92M |
| 2019 | $155M | -$60M | 0.0% | -35.4% | -$34M | $48M | $18M |
| 2018 | $113M | -$62M | 0.0% | -53.4% | -$42M | $20M | $28M |
| 2017 | $73M | -$47M | 0.0% | -62.3% | -$39M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $71M | -$111M | 0.0% | -150.5% | $18M | $153M | $60M |
| Dec '25 | $75M | -$91M | 0.0% | -115.3% | $10M | $153M | $51M |
| Sep '25 | $76M | -$22M | 52.6% | -22.9% | -$719000 | $153M | $40M |
| Jun '25 | $81M | -$41M | 0.0% | -46.0% | -$9M | $153M | $51M |
| Mar '25 | $79M | -$24M | 0.0% | -25.4% | -$390000 | $383M | $342M |
| Dec '24 | $80M | -$21M | 0.0% | -22.0% | -$4M | $382M | $250M |
| Sep '24 | $76M | -$15M | 47.5% | -17.9% | $6M | $345M | $328M |
| Jun '24 | $76M | -$14M | 0.0% | -20.8% | $1M | $0 | $202M |
| Mar '24 | $75M | -$21M | 0.0% | -30.5% | $10M | $228M | $201M |
| Dec '23 | $75M | -$30M | 0.0% | -43.7% | -$19M | $228M | $106M |
| Sep '23 | $74M | -$22M | 0.0% | -33.3% | $3M | $228M | $95M |
| Jun '23 | $73M | -$33M | 0.0% | -47.3% | -$12M | $227M | $116M |
| Mar '23 | $74M | -$33M | 0.0% | -47.3% | -$6M | $227M | $133M |
| Dec '22 | $69M | -$36M | 0.0% | -53.1% | -$15M | $227M | $116M |
| Sep '22 | $68M | -$46M | 0.0% | -66.9% | -$13M | $226M | $124M |
| Jun '22 | $71M | -$33M | 0.0% | -47.0% | -$10M | $226M | $177M |
| Mar '22 | $68M | -$22M | 0.0% | -35.8% | $802000 | $225M | $198M |
| Dec '21 | $65M | -$49M | 0.0% | -69.2% | -$10M | $181M | $193M |
| Sep '21 | $62M | -$40M | 0.0% | -68.4% | -$7M | $0 | $276M |
| Jun '21 | $60M | -$36M | 0.0% | -54.2% | -$7M | $0 | $205M |
How the market has priced HCAT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Health Catalyst, Inc.'s revenue has grown 10.5% per year. These are computed facts, not advice.
As of FY2025, Health Catalyst, Inc. reported $153M of total debt against $51M of cash.
In FY2025, gross margin was —, operating margin -51.7%, and net margin -57.2%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.